Get the Stockscreener App
3.65
5.19%
-0.20
After Hours:
3.67
0.02
+0.55%
Quantum Biopharma Ltd stock is traded at $3.65, with a volume of 43,606.
It is down -5.19% in the last 24 hours and down -47.56% over the past month.
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
See More
Previous Close:
$3.85
Open:
$3.85
24h Volume:
43,606
Relative Volume:
0.43
Market Cap:
$14.03M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.89%
1M Performance:
-47.56%
6M Performance:
-70.00%
1Y Performance:
-36.58%
1-Day Range:
$3.65
$3.981
1-Week Range:
$3.65
$4.29
52-Week Range:
$2.06
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Compare QNTM vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
3.65 | 14.80M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Quantum Biopharma Ltd Stock (QNTM) Latest News
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Portnoy Law Firm Announces Class Action on Behalf of Quantum Corporation Investors - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma - GlobeNewswire
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares - El Paso Times
FinancialContentCONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM - FinancialContent
Quantum Biopharma Ltd. Class Action Notice for Investors - Intellectia AI
Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors - GlobeNewswire
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming DeadlinesQNTM - Prime Publishers, Inc.
Targets Report: Will Quantum BioPharma Ltd stock benefit from M A2025 Bull vs Bear & Free Community Consensus Stock Picks - baoquankhu1.vn
Will Quantum BioPharma Ltd stock benefit from M AMarket Trend Report & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Quantum Biopharma Shareholders File Class Action Lawsuit - intellectia.ai
Quantum Biopharma Ltd. Class Action Alert for Investors - intellectia.ai
Quantum Biopharma Reports Q3 2025 Financial Results - MSN
QNTM Stockholders Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
Risk Recap: Will QNTM stock go up in YEARJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - baoquankhu1.vn
QNTM Shareholders Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
QNTM Investors Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Quantum Biopharma Ltd. Faces Class Action Lawsuit Over Alleged Securities Fraud - intellectia.ai
User - FinancialContent
Quantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The Surge - MSN
Why Quantum BioPharma Ltd. (0K91) stock signals breakout potentialWeekly Stock Analysis & Weekly Watchlist for Hot Stocks - bollywoodhelpline.com
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
Aug Mood: Should I hold or sell Quantum BioPharma Ltd now - baoquankhu1.vn
QNTM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Quantum Biopharma Ltd. to Contact the Firm Today! - accessnewswire.com
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Quantum Biopharma Ltd. to Contact the Firm Today! - accessnewswire.com
Aug Outlook: Will Quantum BioPharma Ltd. outperform during market ralliesVolume Spike & Low Volatility Stock Recommendations - baoquankhu1.vn
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM - Chartmill
Whittier Daily News - FinancialContent
Buyback Watch: Will Quantum BioPharma Ltd. stock attract ESG investors2025 Growth vs Value & Fast Entry and Exit Trade Plans - Bộ Nội Vụ
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026 - NewMediaWire
Spoofing Allegations Against Banks Take Center Stage in Biotech’s Legal Fight - InvestorNews
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
About Us - FinancialContent
QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in - The National Law Review
Quantum BioPharma closes private placement, enhances governance - MSN
QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in a Securities Fraud LawsuitContact Kaplan Fox & Kilsheimer LLP - NewMediaWire
Daily Breeze - FinancialContent
Deadline to Lead in Securities Class Action Against Quantum Biopharma Ltd. (QNTM) is February 23, 2026Contact Kaplan Fox - NewMediaWire
Deadline to Lead in Securities Class Action Against Quantum Bioph - The National Law Review
Quantum Biopharma Ltd Stock (QNTM) Financials Data
There is no financial data for Quantum Biopharma Ltd (QNTM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):